Promises and challenges of genetic therapy for blindness.
Cremers
Frans P M
FP
Department of Human Genetics, Radboud University Nijmegen Medical Centre, 6500 HB Nijmegen, Netherlands. F.Cremers@antrg.umcn.nl
Collin
Rob W J
RW
D000328:Adult; D000367:Age Factors; D000818:Animals; D002352:Carrier Proteins / Q000235:genetics*; D000229:Dependovirus; D004195:Disease Models, Animal; D005136:Eye Proteins / Q000235:genetics*; D015316:Genetic Therapy / Q000379:methods* / Q000639:trends; D005822:Genetic Vectors / Q000627:therapeutic use; D006801:Humans; D007231:Infant, Newborn; D051379:Mice; D009154:Mutation / Q000235:genetics; D029242:Optic Atrophy, Hereditary, Leber / Q000235:genetics / Q000628:therapy; D019745:cis-trans-Isomerases; D000099178:Retinoid Isomerohydrolase
D002352:Carrier Proteins; D005136:Eye Proteins; D019745:cis-trans-Isomerases; D000099178:Retinoid Isomerohydrolase